ADVANCED GLYCATION IN DIABETIC RENAL AND VASCULAR-DISEASE

[1] BROWNLEE M, 1988, NEW ENGL J MED, V318, P1315

[2] LIPID ADVANCED GLYCOSYLATION - PATHWAY FOR LIPID OXIDATION IN-VIVO [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (14) : 6434 - 6438

[3] MODIFICATION OF LOW-DENSITY-LIPOPROTEIN BY ADVANCED GLYCATION END-PRODUCTS CONTRIBUTES TO THE DYSLIPIDEMIA OF DIABETES AND RENAL-INSUFFICIENCY [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (20) : 9441 - 9445

[4] DOI T, 1992, P NATL ACAD SCI USA, V89, P2873, DOI 10.1073/pnas.89.7.2873

[5] RECEPTOR-SPECIFIC INDUCTION OF INSULIN-LIKE GROWTH FACTOR-I IN HUMAN MONOCYTES BY ADVANCED GLYCOSYLATION END-PRODUCT MODIFIED PROTEINS [J]. JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (02) : 439 - 446

[6] ADVANCED PROTEIN GLYCOSYLATION INDUCES TRANSENDOTHELIAL HUMAN MONOCYTE CHEMOTAXIS AND SECRETION OF PLATELET-DERIVED GROWTH-FACTOR - ROLE IN VASCULAR-DISEASE OF DIABETES AND AGING [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (22) : 9010 - 9014

[7] MAKITA Z, 1992, J BIOL CHEM, V267, P5133

[8] ADVANCED GLYCOSYLATION END-PRODUCTS IN PATIENTS WITH DIABETIC NEPHROPATHY [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (12) : 836 - 842

[9] REACTIVE GLYCOSYLATION ENDPRODUCTS IN DIABETIC UREMIA AND TREATMENT OF RENAL-FAILURE [J]. LANCET, 1994, 343 (8912) : 1519 - 1522

[10] HUMAN AND RAT MESANGIAL CELL RECEPTORS FOR GLUCOSE-MODIFIED PROTEINS - POTENTIAL ROLE IN KIDNEY TISSUE REMODELING AND DIABETIC NEPHROPATHY [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (04) : 931 - 939

[1] BROWNLEE M, 1988, NEW ENGL J MED, V318, P1315

[2] LIPID ADVANCED GLYCOSYLATION - PATHWAY FOR LIPID OXIDATION IN-VIVO [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (14) : 6434 - 6438

[3] MODIFICATION OF LOW-DENSITY-LIPOPROTEIN BY ADVANCED GLYCATION END-PRODUCTS CONTRIBUTES TO THE DYSLIPIDEMIA OF DIABETES AND RENAL-INSUFFICIENCY [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (20) : 9441 - 9445

[4] DOI T, 1992, P NATL ACAD SCI USA, V89, P2873, DOI 10.1073/pnas.89.7.2873

[5] RECEPTOR-SPECIFIC INDUCTION OF INSULIN-LIKE GROWTH FACTOR-I IN HUMAN MONOCYTES BY ADVANCED GLYCOSYLATION END-PRODUCT MODIFIED PROTEINS [J]. JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (02) : 439 - 446

[6] ADVANCED PROTEIN GLYCOSYLATION INDUCES TRANSENDOTHELIAL HUMAN MONOCYTE CHEMOTAXIS AND SECRETION OF PLATELET-DERIVED GROWTH-FACTOR - ROLE IN VASCULAR-DISEASE OF DIABETES AND AGING [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (22) : 9010 - 9014

[7] MAKITA Z, 1992, J BIOL CHEM, V267, P5133

[8] ADVANCED GLYCOSYLATION END-PRODUCTS IN PATIENTS WITH DIABETIC NEPHROPATHY [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (12) : 836 - 842

[9] REACTIVE GLYCOSYLATION ENDPRODUCTS IN DIABETIC UREMIA AND TREATMENT OF RENAL-FAILURE [J]. LANCET, 1994, 343 (8912) : 1519 - 1522

[10] HUMAN AND RAT MESANGIAL CELL RECEPTORS FOR GLUCOSE-MODIFIED PROTEINS - POTENTIAL ROLE IN KIDNEY TISSUE REMODELING AND DIABETIC NEPHROPATHY [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (04) : 931 - 939